GO:0006285 base-excision repair, AP site formation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006285 describes the enzymatic step in base excision repair (BER) where a DNA glycosylase removes a damaged base, creating an apurinic/apyrimidinic (AP) site.
• AP site formation is the first committed step of BER and is essential for removing oxidized, alkylated, or deaminated bases.
• The reaction is catalyzed by DNA glycosylases, which hydrolyze the N-glycosidic bond between the altered base and the deoxyribose sugar.
• AP sites are cytotoxic and mutagenic if unrepaired; they are recognized by AP endonucleases such as APE1, which incises the DNA backbone.
• Defects in AP site formation are linked to cancer, neurodegeneration, and aging, making this pathway a target for therapeutic and biomarker research.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise dissection of glycosylase function in AP site formation.
Description
Base-excision repair (BER) is the primary DNA repair pathway that removes small, non-helix-distorting base lesions caused by oxidation, alkylation, deamination, or hydrolysis. The very first step of BER is the formation of an apurinic/apyrimidinic (AP) site, a deoxyribose sugar with a missing base, which is catalyzed by DNA glycosylases. This process is annotated by the Gene Ontology term GO:0006285, base-excision repair, AP site formation. Without this step, damaged bases persist and can lead to mutations, strand breaks, and cell death. AP site formation is not a single event but a family of reactions carried out by distinct DNA glycosylases, each recognizing specific altered bases. For example, oxidized bases are removed by OGG1, while deaminated bases are removed by UNG or MBD4. The resulting AP site is a substrate for AP endonucleases, which nick the DNA backbone to allow downstream repair synthesis and ligation. Because AP sites are both cytotoxic and mutagenic, their formation and subsequent repair are tightly regulated and coordinated with other DNA repair pathways. For researchers, GO:0006285 provides a precise functional annotation to study the initiation of BER. Understanding AP site formation is critical for cancer biology, aging research, and the development of drugs that target DNA repair. This article reviews the mechanism, key genes, disease links, and experimental models for studying AP site formation, with a focus on CRISPR-based approaches.
base-excision repair, AP site formation At A Glance
| GO ID | GO:0006285 |
|---|---|
| GO term | base-excision repair, AP site formation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Enzymatic removal of damaged bases by DNA glycosylases to create an AP site, the first step of base excision repair |
| Parent pathway | Base excision repair (GO:0006284) |
| Cellular location | Nucleus, mitochondria |
| Key enzymes | DNA glycosylases (e.g., OGG1, UNG, MUTYH, NTHL1, NEIL1/2) |
| Downstream step | AP site cleavage by AP endonucleases (e.g., APE1) |
What Is GO:0006285?
GO:0006285, base-excision repair, AP site formation, is defined as the formation of an AP site, a deoxyribose sugar with a missing base, by a DNA glycosylase that recognizes an altered base in DNA and catalyzes its hydrolytic removal. This sugar phosphate is the substrate recognized by the AP endonuclease, which cuts the DNA phosphodiester backbone at the 5' side of the altered site to leave a gap that is subsequently repaired.
Why Is base-excision repair, AP site formation Important in Cell Biology?
AP site formation is the rate-limiting and most lesion-specific step of BER, determining which damaged bases are removed and when repair is initiated. Because AP sites are both cytotoxic and mutagenic, their proper formation and timely repair are essential for genome stability. Defects in this step cause accumulation of mutations and are associated with cancer predisposition, neurodegeneration, and premature aging. Moreover, AP site formation is a target for cancer therapy, as inhibiting glycosylases can sensitize tumors to DNA-damaging agents.
• Initiates the entire base excision repair pathway by creating AP sites.
• Removes oxidized, alkylated, and deaminated bases that would otherwise cause mutations.
• Prevents cytotoxicity and strand breaks from unrepaired AP sites.
• Defects in glycosylases are linked to cancer (e.g., MUTYH-associated polyposis).
• Plays a role in aging and neurodegeneration through accumulation of DNA damage.
• Is a target for chemotherapeutic strategies that exploit DNA repair defects.
• Enables precise genome editing research via CRISPR models of glycosylase genes.
• Provides biomarkers for cancer risk and treatment response.
• Coordinates with other repair pathways such as single-strand break repair.
• Is essential for mitochondrial DNA maintenance and cellular energetics.
What Happens During base-excision repair, AP site formation?
Recognition of damaged bases by DNA glycosylases
In simple terms: Specialized enzymes scan DNA for damaged bases and flip them out of the double helix.
DNA glycosylases continuously survey the genome for altered bases such as oxidized guanine, deaminated cytosine, or alkylated adenine. Each glycosylase has a specificity for particular lesions; for example, OGG1 recognizes 8-oxoguanine, UNG recognizes uracil, and MUTYH recognizes adenine opposite 8-oxoguanine. Upon recognition, the enzyme flips the damaged base out of the DNA helix into its active site, a process that is facilitated by DNA bending and base-stacking interactions.
Catalytic removal of the base and AP site formation
In simple terms: The enzyme cuts the bond between the damaged base and the sugar, leaving an AP site.
Once the damaged base is flipped into the active site, the glycosylase catalyzes hydrolysis of the N-glycosidic bond, releasing the free base and creating an apurinic/apyrimidinic (AP) site. This reaction is conserved across species and is the defining step of GO:0006285. The AP site is a deoxyribose sugar with a missing base, which is chemically unstable and can lead to strand breaks if not processed.
Substrate specificity and lesion diversity
In simple terms: Different glycosylases handle different types of DNA damage.
The formation of AP sites is carried out by a family of glycosylases with overlapping but distinct substrate specificities. Monofunctional glycosylases (e.g., UNG, MUTYH) only remove the base, while bifunctional glycosylases (e.g., OGG1, NTHL1, NEIL1/2) also possess AP lyase activity that can cleave the DNA backbone. This diversity ensures that a wide range of lesions, including oxidized, alkylated, and deaminated bases, are efficiently removed.
Coordination with downstream BER factors
In simple terms: After AP site formation, other repair proteins take over to fix the DNA.
The AP site generated by glycosylases is recognized by AP endonucleases, primarily APE1 in humans, which incises the DNA backbone 5' to the AP site. This incision creates a single-strand break that is further processed by polymerase beta and ligase III/XRCC1. Protein-protein interactions, including those mediated by PARP-1, facilitate the handoff between glycosylases and downstream factors. Dysregulation of this coordination can lead to repair defects and genomic instability.
Regulation of AP site formation
In simple terms: Cells control when and where AP sites are made to avoid excessive damage.
AP site formation is regulated at multiple levels, including enzyme expression, post-translational modifications, and chromatin context. Acetylation of glycosylases and other BER proteins can modulate their activity and interactions. In nucleosomes, the accessibility of damaged bases to glycosylases is influenced by histone modifications and chromatin remodeling. These regulatory mechanisms ensure that AP site formation is tightly coupled to cell cycle and DNA damage response.
Key Genes Involved in GO:0006285 base-excision repair, AP site formation
The following genes encode DNA glycosylases and associated factors that directly catalyze or regulate AP site formation in base excision repair.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OGG1 | Removes 8-oxoguanine, a major oxidative lesion | Linked to cancer and neurodegeneration; target for inhibitors |
| UNG | Removes uracil from DNA | Important for antibody diversity and viral defense |
| MUTYH | Removes adenine mispaired with 8-oxoguanine | MUTYH-associated polyposis, a colorectal cancer syndrome |
| NTHL1 | Removes oxidized pyrimidines | Bifunctional glycosylase; mutations in cancer |
| NEIL1 | Removes oxidized pyrimidines and formamidopyrimidines | Associated with metabolic syndrome and cancer |
| NEIL2 | Removes oxidized bases in transcribed regions | Role in transcription-coupled BER |
| NEIL3 | Removes oxidized bases in telomeres and during replication | Implicated in cancer and stem cell maintenance |
| MBD4 | Removes deaminated methylcytosine (thymine) | Mutated in colorectal cancer and leukemia |
| TDG | Removes deaminated cytosine and 5-methylcytosine | Epigenetic regulation and embryonic development |
| SMUG1 | Removes uracil and oxidized pyrimidines | Backup for UNG; role in somatic hypermutation |
| APEX1 | AP endonuclease that incises AP sites | Essential for BER; target for cancer therapy |
| APEX2 | Backup AP endonuclease | Important in mitochondria and backup BER |
| POLB | DNA polymerase beta, fills gaps after AP site cleavage | Key downstream factor; mutations in cancer |
| XRCC1 | Scaffold protein coordinating BER | Defects cause sensitivity to DNA damage |
| PARP1 | Poly(ADP-ribose) polymerase, recruits BER factors | Target for cancer drugs (PARP inhibitors) |
| LIG3 | DNA ligase III, seals nicks after repair | Essential for BER and mitochondrial DNA repair |
| FEN1 | Flap endonuclease, processes repair intermediates | Role in long-patch BER |
| PCNA | Proliferating cell nuclear antigen, coordinates repair | Involved in long-patch BER |
How Is base-excision repair, AP site formation Regulated?
AP site formation is regulated by post-translational modifications, protein-protein interactions, and chromatin context. Acetylation of glycosylases and other BER proteins can modulate their enzymatic activity and recruitment to damage sites. PARP-1 is rapidly activated by DNA strand breaks and facilitates the assembly of BER complexes, including the handoff between glycosylases and APE1. In nucleosomes, the accessibility of damaged bases to glycosylases is influenced by histone modifications and chromatin remodeling, which can either promote or inhibit AP site formation. Additionally, the expression of glycosylases is regulated at the transcriptional level in response to oxidative stress and during the cell cycle.
base-excision repair, AP site formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MUTYH | MUTYH-associated polyposis, colorectal cancer | Knockout colon organoids; point-mutation knock-in mice |
| OGG1 | Lung cancer, neurodegeneration, aging | OGG1 knockout cell lines; overexpression in neurons |
| NEIL1 | Metabolic syndrome, cancer | Liver-specific knockout mice; CRISPR knock-in of variants |
| APEX1 | Cancer, chemoresistance | APE1 knockout cells; point mutation of catalytic residue |
| MBD4 | Colorectal cancer, leukemia | MBD4 knockout hematopoietic stem cells; knock-in of patient mutations |
Cancer
Defects in AP site formation lead to accumulation of mutations and genomic instability, driving cancer development. For example, biallelic mutations in MUTYH cause MUTYH-associated polyposis, a hereditary colorectal cancer syndrome. Reduced expression or activity of OGG1 and NEIL1 has been observed in various cancers and is associated with increased mutation burden. Targeting glycosylases or downstream BER factors such as APE1 and PARP1 is a promising therapeutic strategy, especially in tumors with homologous recombination defects.
Neurodegeneration and aging
Neurons are particularly vulnerable to oxidative DNA damage due to high metabolic activity and limited proliferative capacity. Impaired AP site formation by OGG1 or NEIL1 has been linked to neurodegeneration and accelerated aging in animal models. Naked mole rat cells, which are long-lived and cancer-resistant, display more efficient excision repair than mouse cells, suggesting that robust BER contributes to longevity. Accumulation of AP sites and unrepaired oxidative lesions is a hallmark of aging tissues.
Mitochondrial dysfunction
Mitochondria contain their own DNA and rely on BER for maintenance. AP site formation in mitochondria is carried out by glycosylases such as OGG1 and UNG, and defects can lead to mitochondrial DNA mutations and respiratory chain dysfunction. APE2 is important for mitochondrial BER, and its loss sensitizes cells to oxidative stress. Mitochondrial BER defects have been implicated in metabolic diseases and neurodegeneration.
From base-excision repair, AP site formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a glycosylase increase AP sites and mutations? | CRISPR knockout cell lines (e.g., OGG1, UNG) followed by AP site quantification |
| Does a specific point mutation in a glycosylase affect substrate specificity? | CRISPR point-mutation knock-in (e.g., OGG1 catalytic mutant) |
| Can a tagged glycosylase be used to track AP site formation in live cells? | Knock-in of fluorescent or epitope tag (e.g., GFP-OGG1) |
| Does overexpression of a glycosylase protect against oxidative stress? | Overexpression cell models (e.g., lentiviral OGG1) |
| What is the role of a glycosylase in tumor growth? | Xenograft models with knockout or overexpression cells |
| How does a glycosylase mutation affect BER coordination? | Knock-in of patient-derived mutations in isogenic cell lines |
How to Study the base-excision repair, AP site formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro BER assay | Glycosylase activity and AP site formation | Testing purified enzymes or cell extracts |
| ARP assay | Cellular AP site levels | Quantifying DNA damage after oxidative stress |
| Alkaline comet assay | AP sites and strand breaks | Assessing repair capacity in cells |
| CRISPR knockout screen | Genes required for AP site formation | Identifying novel BER factors |
| Crystallography/cryo-EM | 3D structure of glycosylase-DNA complexes | Understanding base flipping and catalysis |
| Surface plasmon resonance | Binding kinetics of glycosylases to DNA | Measuring affinity of mutants |
| Mass spectrometry | Identification of glycosylase interactors | Mapping BER protein complexes |
In vitro reconstitutive BER assays
Reconstitutive BER assays using purified proteins or cell extracts can measure AP site formation and subsequent repair steps. These assays typically use oligonucleotide substrates containing specific lesions and monitor glycosylase activity by gel electrophoresis or fluorescence. They are essential for dissecting the enzymatic mechanism and for testing inhibitors.
AP site quantification
AP sites can be quantified using aldehyde-reactive probes, such as ARP (aldehyde reactive probe), which reacts with the aldehyde group of the AP site. Comet assays under alkaline conditions can also detect AP sites and strand breaks. These methods are used to assess the impact of glycosylase knockout or overexpression on cellular AP site levels.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for AP site formation and BER. Libraries targeting DNA repair genes can be used to find synthetic lethal interactions with DNA-damaging agents. Bioinformatics analysis of screening data can reveal pathways and networks involved in AP site formation.
Structural and biophysical methods
X-ray crystallography, NMR, and cryo-EM have provided detailed structures of glycosylases bound to DNA substrates, revealing the base-flipping mechanism. Surface plasmon resonance and isothermal titration calorimetry can measure binding affinities and kinetics. These methods are crucial for understanding how mutations affect AP site formation.
How CRISPR Can Be Used to Study GO:0006285 base-excision repair, AP site formation
Knockout
CRISPR knockout of glycosylase genes (e.g., OGG1, UNG, MUTYH) creates cell models to study the consequences of loss of AP site formation. These models can be used to measure AP site accumulation, mutation rates, and sensitivity to DNA-damaging agents. Knockout cells are also valuable for identifying backup pathways and synthetic lethal interactions.
Point Mutation
CRISPR point mutation can introduce catalytic-dead or patient-derived mutations into glycosylase genes to dissect specific functions. For example, mutating the catalytic residue of OGG1 allows separation of its glycosylase activity from other functions. These models are essential for understanding how specific mutations contribute to disease.
Knock-in
Knock-in of tagged glycosylases (e.g., GFP-OGG1) enables live-cell imaging and chromatin immunoprecipitation to track AP site formation at specific genomic loci. Knock-in of disease-associated variants into isogenic cell lines provides a controlled system to study their impact on BER.
Overexpression
Overexpression of glycosylases can protect cells from oxidative damage or, conversely, cause excessive AP site formation and toxicity. Overexpression models are useful for testing whether increased AP site formation enhances repair capacity or sensitizes cells to specific drugs.
How EDITGENE Supports base-excision repair, AP site formation Research
Researchers studying base-excision repair, AP site formation-related genes often need to determine whether a candidate gene is causally involved in DNA repair, whether a specific mutation alters glycosylase activity, or whether overexpression is protective or toxic. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for these questions.
Contact EDITGENE today to design your custom CRISPR model for base-excision repair, AP site formation research.
Frequently Asked Questions About base-excision repair, AP site formation
What is base-excision repair, AP site formation?
It is the first step of base excision repair where a DNA glycosylase removes a damaged base, creating an AP site (apurinic/apyrimidinic site).
What genes are involved in base-excision repair, AP site formation?
Key genes include OGG1, UNG, MUTYH, NTHL1, NEIL1/2/3, MBD4, TDG, and SMUG1, which encode DNA glycosylases.
What is the GO ID for base-excision repair, AP site formation?
The Gene Ontology ID is GO:0006285.
Why are AP sites important?
AP sites are cytotoxic and mutagenic; if unrepaired, they can block DNA replication and transcription and lead to mutations.
How are AP sites detected?
AP sites can be detected using aldehyde-reactive probes, alkaline comet assays, or by measuring glycosylase activity in vitro.
What diseases are linked to defects in AP site formation?
Defects are linked to cancer (e.g., MUTYH-associated polyposis), neurodegeneration, and aging.
What is the difference between monofunctional and bifunctional glycosylases?
Monofunctional glycosylases only remove the base, while bifunctional glycosylases also have AP lyase activity that cleaves the DNA backbone.
How does APE1 relate to AP site formation?
APE1 is the major AP endonuclease that incises the DNA backbone at AP sites created by glycosylases, preparing them for repair.
Can CRISPR be used to study AP site formation?
Yes, CRISPR knockout, point mutation, and knock-in models allow precise manipulation of glycosylase genes to study AP site formation.
What are the research methods for studying AP site formation?
Common methods include in vitro BER assays, AP site quantification, CRISPR screens, and structural biology techniques.
Conclusion
GO:0006285, base-excision repair, AP site formation, is the initiating and lesion-specific step of BER, catalyzed by DNA glycosylases. It is essential for genome stability and is implicated in cancer, neurodegeneration, and aging. Understanding its mechanism and regulation provides opportunities for therapeutic intervention and biomarker development. CRISPR-based models are powerful tools to dissect the roles of individual glycosylases and to identify new factors in this pathway.
References
- 1. Jaiswal AS et al.. 2023. In Vitro Reconstitutive Base Excision Repair (BER) Assay.. Methods Mol Biol 2701:91-112 PMID: 37574477
- 2. Evdokimov A et al.. 2018. Naked mole rat cells display more efficient excision repair than mouse cells.. Aging (Albany NY) 10(6):1454-1473 PMID: 29930219
- 3. Endutkin AV et al.. 2019. Transient protein-protein complexes in base excision repair.. J Biomol Struct Dyn 37(17):4407-4418 PMID: 30488779
- 4. Sliwiński T et al.. 2005. [Base excision repair].. Postepy Biochem 51(2):120-9 PMID: 16209349
- 5. Kim DV et al.. 2023. Back-Up Base Excision DNA Repair in Human Cells Deficient in the Major AP Endonuclease, APE1.. Int J Mol Sci 25(1) PMID: 38203235
- 6. Bhakat KK et al.. 2020. Fine-tuning of DNA base excision/strand break repair via acetylation.. DNA Repair (Amst) 93:102931 PMID: 33087268
- 7. Sutton TB et al.. 2024. Global screening of base excision repair in nucleosome core particles.. DNA Repair (Amst) 144:103777 PMID: 39476546
- 8. Prasad R et al.. 2015. Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair.. PLoS One 10(5):e0124269 PMID: 26020771
